195 related articles for article (PubMed ID: 24662676)
1. A role for CD81 and hepatitis C virus in hepatoma mobility.
Brimacombe CL; Wilson GK; Hübscher SG; McKeating JA; Farquhar MJ
Viruses; 2014 Mar; 6(3):1454-72. PubMed ID: 24662676
[TBL] [Abstract][Full Text] [Related]
2. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
3. Hepatoma polarization limits CD81 and hepatitis C virus dynamics.
Harris HJ; Clerte C; Farquhar MJ; Goodall M; Hu K; Rassam P; Dosset P; Wilson GK; Balfe P; Ijzendoorn SC; Milhiet PE; McKeating JA
Cell Microbiol; 2013 Mar; 15(3):430-45. PubMed ID: 23126643
[TBL] [Abstract][Full Text] [Related]
4. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
[TBL] [Abstract][Full Text] [Related]
5. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
6. CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.
Zona L; Tawar RG; Zeisel MB; Xiao F; Schuster C; Lupberger J; Baumert TF
Viruses; 2014 Feb; 6(2):875-92. PubMed ID: 24553110
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
[TBL] [Abstract][Full Text] [Related]
8. EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.
Potel J; Rassam P; Montpellier C; Kaestner L; Werkmeister E; Tews BA; Couturier C; Popescu CI; Baumert TF; Rubinstein E; Dubuisson J; Milhiet PE; Cocquerel L
Cell Microbiol; 2013 Jul; 15(7):1234-52. PubMed ID: 23351194
[TBL] [Abstract][Full Text] [Related]
9. CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.
Bunz M; Eisele M; Hu D; Ritter M; Kammerloher J; Lampl S; Schindler M
Front Cell Infect Microbiol; 2024; 14():1338606. PubMed ID: 38357447
[TBL] [Abstract][Full Text] [Related]
10. CD81 and hepatitis C virus (HCV) infection.
Fénéant L; Levy S; Cocquerel L
Viruses; 2014 Feb; 6(2):535-72. PubMed ID: 24509809
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Mimics Effects of Glypican-3 on CD81 and Promotes Development of Hepatocellular Carcinomas via Activation of Hippo Pathway in Hepatocytes.
Xue Y; Mars WM; Bowen W; Singhi AD; Stoops J; Michalopoulos GK
Am J Pathol; 2018 Jun; 188(6):1469-1477. PubMed ID: 29577937
[TBL] [Abstract][Full Text] [Related]
12. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
[TBL] [Abstract][Full Text] [Related]
13. CD81
Ashraf Malik M; Ishtiyaq Ali Mirza J; Umar M; Manzoor S
Viral Immunol; 2019 Dec; 32(10):453-462. PubMed ID: 31755827
[TBL] [Abstract][Full Text] [Related]
14. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
[TBL] [Abstract][Full Text] [Related]
15. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
16. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection.
Montpellier C; Tews BA; Poitrimole J; Rocha-Perugini V; D'Arienzo V; Potel J; Zhang XA; Rubinstein E; Dubuisson J; Cocquerel L
J Biol Chem; 2011 Apr; 286(16):13954-65. PubMed ID: 21343309
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
Sarhan MA; Chen AY; Michalak TI
PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol sensing by CD81 is important for hepatitis C virus entry.
Palor M; Stejskal L; Mandal P; Lenman A; Alberione MP; Kirui J; Moeller R; Ebner S; Meissner F; Gerold G; Shepherd AJ; Grove J
J Biol Chem; 2020 Dec; 295(50):16931-16948. PubMed ID: 32900848
[TBL] [Abstract][Full Text] [Related]
19. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
Witteveldt J; Evans MJ; Bitzegeio J; Koutsoudakis G; Owsianka AM; Angus AG; Keck ZY; Foung SK; Pietschmann T; Rice CM; Patel AH
J Gen Virol; 2009 Jan; 90(Pt 1):48-58. PubMed ID: 19088272
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.
Rajesh S; Sridhar P; Tews BA; Fénéant L; Cocquerel L; Ward DG; Berditchevski F; Overduin M
J Virol; 2012 Sep; 86(18):9606-16. PubMed ID: 22740401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
